These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1283 related articles for article (PubMed ID: 28859660)

  • 1. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease.
    Wattmo C; Blennow K; Hansson O
    BMC Neurol; 2020 Jan; 20(1):10. PubMed ID: 31918679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.
    Wattmo C; Londos E; Minthon L
    Curr Alzheimer Res; 2018; 15(10):905-916. PubMed ID: 29732972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
    Wattmo C; Londos E; Minthon L
    BMC Neurol; 2014 Sep; 14():173. PubMed ID: 25213579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
    Polsinelli AJ; Logan PE; Lane KA; Manchella MK; Nemes S; Sanjay AB; Gao S; Apostolova LG
    Alzheimers Dement; 2023 May; 19(5):1983-1993. PubMed ID: 36394443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort.
    Wattmo C; Wallin AK; Minthon L
    BMC Neurol; 2012 Nov; 12():134. PubMed ID: 23126532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.
    Wattmo C; Londos E; Minthon L
    Dement Geriatr Cogn Disord; 2015; 40(5-6):297-310. PubMed ID: 26335053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
    Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M;
    Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.
    Wattmo C; Wallin AK; Minthon L
    Alzheimers Res Ther; 2013; 5(5):44. PubMed ID: 24099236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.
    Wattmo C; Londos E; Minthon L
    BMC Neurol; 2016 Aug; 16(1):156. PubMed ID: 27581368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
    Wattmo C; Londos E; Minthon L
    Clin Interv Aging; 2014; 9():1951-62. PubMed ID: 25484578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
    Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI
    J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression.
    Wattmo C; Wallin ÅK
    Dement Geriatr Cogn Dis Extra; 2017; 7(1):172-187. PubMed ID: 28626471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study.
    Boccardi V; Baroni M; Smirne N; Clodomiro A; Ercolani S; Longo A; Ruggiero C; Bruni AC; Mecocci P
    J Alzheimers Dis; 2017; 56(1):239-248. PubMed ID: 27911323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of long-term cognitive outcome in Alzheimer's disease.
    Wattmo C; Wallin AK; Londos E; Minthon L
    Alzheimers Res Ther; 2011 Jul; 3(4):23. PubMed ID: 21774798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.